Aetion
Lital Aravot is an experienced professional in the life sciences and healthcare sectors, currently serving as the Director and Engagement Lead at Aetion since October 2019. Prior to this role, Lital held various positions at Signals Analytics from October 2015 to September 2019, including Commercial Growth Executive, Solutions Consultant, and Healthcare Consulting Team Leader. Lital's earlier experience includes technical writing at Teva Pharmaceuticals and translation of clinical trial documents at TransCom Global Ltd. As a research assistant at the Weizmann Institute of Science, Lital contributed to the Molecular Biology Department. Lital Aravot holds multiple degrees, including a Master's in Business Administration from Tel Aviv University and ongoing studies at Keio University, complemented by a Master's in Medical Science and a Bachelor's in Biotechnology.
This person is not in any offices
Aetion
9 followers
Aetion is a health care technology company that delivers real-world evidence for life sciences, payers, providers, and regulatory agencies. The Aetion Evidence Platform analyzes data from the real world to produce transparent, rapid, and scientifically validated answers on treatments, costs, and outcomes. Founded by Harvard Medical School faculty members with decades of experience in epidemiology and health outcomes research, Aetion informs health care’s most critical decisions — what works best, for whom, and when — to guide treatment development, commercialization, and payment innovation into health care’s modern era.